Atopic Dermatitis (Eczema) Study (Up to $100) From Home

At Sanguine, we are accelerating medicine with the help of volunteers like you. You can contribute to the development of new treatments and help advance atopic dermatitis (eczema) research with a 15-minute blood donation.

Donating is fast, easy, and you will receive up to $100 for your time without leaving home.

You may qualify to participate if you:

Are 18 to 65 years of age Are diagnosed with atopic dermatitis (eczema)Are not taking herbal supplements (e.g. echinacea, ginseng, ashwagandha, saw palmetto, resveratrol), probiotics, and prebioticsAre not undergoing treatment with Xeljanz (tofacitinib), Olumiant (baricitinib), Jakafi (ruxolitinib), Rinvoq (upadacitinib), Inrebic (fedratinib), Cibinqo (abrocitinib), Opzelura (ruxolitinib), Litfulo (ritlecitinib), Eucrisa (crisaborole), and Dupixent (dupilimab) at the time of screening and/or sample collectionAre not undergoing treatment with systemic steroids (oral or injectable) glucocorticoids, and/or cortisones (prednisone. prednisolone, methylprednisone)Are not undergoing treatment with oral and injectable calcineurin inhibitors (cyclosporine, tacrolimus) at the time of screening and/or sample collectionAre not undergoing treatment with Aerovant (pitrakinra), Ebglyss (lebrikizumab), Adbry (tralokinumab), and/or Aslan (eblasakimab) at the time of screening and/or sample collection Are not diagnosed with hypertension, high cholesterol, anxiety, depression, GERD, IBS, osteoarthritis, and any chronic or autoimmune conditions such as lupus, rheumatoid arthritis, Crohn’s disease, ulcerative colitis; any form of active cancer; any chronic/active infectious diseases (e.g. HIV, HCV, HBV); diabetes type 1 and 2Lives in the United States

Click here to sign up and call (617)-397-3750 to speak with a research coordinator and see if you qualify

About Sanguine

Sanguine is a leading provider of at-home clinical research services empowering patients to participate in research studies from the comfort of their homes using smart technology and a mobile health staff. For more information, visit sanguinebio.com.